Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery

Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery

An in-depth analysis of nanotechnology applications for the improvement of solubility, distribution, bioavailability and stability of reverse transcriptase inhibitors is reported. Current clinically used nucleoside and non-nucleoside agents, included in combination therapies, were examined in the pr...

Full description

Bibliographic Details
Main Authors: Fedora Grande, Giuseppina Ioele, Maria Antonietta Occhiuzzi, Michele De Luca, Elisabetta Mazzotta, Gaetano Ragno, Antonio Garofalo, Rita Muzzalupo
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Pharmaceutics
Subjects:
HIV
antiretrovirals
nanoformulations
drug degradation
drug protection
Online Access:https://www.mdpi.com/1999-4923/11/5/197

Internet

https://www.mdpi.com/1999-4923/11/5/197

Similar Items